This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Malta, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, United States
The drug VAQTA contains one active pharmaceutical ingredient (API):
|
1
Hepatitis A Virus purified inactivated
UNII Q04Q922K9Q - HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
Inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| VAQTA ADULT Suspension for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| VAQTA PAEDIATRIC Suspension for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07BC02 | Hepatitis A, inactivated, whole virus | J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BC Hepatitis vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 525502501151411, 525502502158411, 525513100016103 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02229702 |
| Country: EE | Ravimiamet | Identifier(s): 1713237 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 61601, 61602 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 144089, 144774, 145292, 145300 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 62087670 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 217330, 30053 |
| Country: HK | Department of Health Drug Office | Identifier(s): 41649, 41651 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 4826 |
| Country: MT | Medicines Authority | Identifier(s): AA1438/00602 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 62049, 96237 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 7513 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100198460, 100224682 |
| Country: SG | Health Sciences Authority | Identifier(s): 10007P, 13717P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699636961360, 8699636961377 |
| Country: US | FDA, National Drug Code | Identifier(s): 0006-4095, 0006-4096, 0006-4831, 0006-4841 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
